As per MRFR analysis, the US Clinical Reference Laboratories Market Size was estimated at 11.04 (USD Billion) in 2023. The US Clinical Reference Laboratories Market Industry is expected to grow from 12.98(USD Billion) in 2024 to 27.17 (USD Billion) by 2035. The US Clinical Reference Laboratories Market CAGR (growth rate) is expected to be around 6.946% during the forecast period (2025 - 2035).
The US Clinical Reference Laboratories Market shows several important trends that shape its landscape. The ongoing shift towards personalized medicine is a significant driver, fostering the development of advanced diagnostic tests tailored to individual patient needs. This trend is amplified by increasing awareness among patients and healthcare providers about the benefits of precision diagnostics, leading to greater adoption of laboratory services. Moreover, the rising prevalence of chronic diseases in the US underscores the demand for comprehensive laboratory testing. As the population ages and lifestyle-related health issues grow, the need for chronic disease management through effective laboratory testing becomes paramount.
There are ample opportunities to be captured in the market, particularly with the integration of technology in laboratory services. The ascent of telehealth has accelerated demand for home testing and remote monitoring solutions, allowing patients to access laboratory services conveniently. Additionally, advancements in artificial intelligence and automation in laboratories are making testing more efficient and accurate, catering to the needs of a busy healthcare system. Regulatory efforts to expedite the approval of innovative testing methods and promote value-based care also provide a fertile ground for growth in the laboratory sector. In recent times, there has been a noticeable increase in partnerships between clinical laboratories and healthcare providers.
These collaborations aim to streamline diagnostic processes and enhance the quality of care. The Covid-19 pandemic has further accelerated the focus on laboratory testing and quick diagnosis, underscoring their vital role in public health preparedness. The US market is also witnessing a push for more robust laboratory information systems to manage data securely and efficiently, reflecting the ongoing digital transformation in healthcare. This blend of technology, increasing healthcare demands, and personalized care continues to propel the evolution of the US Clinical Reference Laboratories Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The United States is experiencing a significant rise in chronic diseases, which is a major driver for the US Clinical Reference Laboratories Market Industry. According to the Centers for Disease Control and Prevention (CDC), approximately six in ten adults in the US have a chronic disease, with heart disease, cancer, and diabetes being the most prevalent. This increasing burden necessitates advanced diagnostic testing, thereby propelling the demand for clinical reference laboratories.
Furthermore, the American Cancer Society reported an estimated 1.9 million new cancer cases in the US in 2022 alone, highlighting the urgent need for precise and timely laboratory testing to manage these conditions. The growing elderly population is another contributing factor, with the U.S. Census Bureau projecting that the number of individuals aged 65 and older will more than double from 52 million in 2018 to 95 million by 2060. This demographic shift will likely escalate the diagnostic requirements, thereby driving the growth of the US Clinical Reference Laboratories Market.
Rapid technological evolution in laboratory testing methods is significantly bolstering the US Clinical Reference Laboratories Market Industry. Innovations such as next-generation sequencing, artificial intelligence in diagnostics, and point-of-care testing have improved the accuracy and speed of laboratory tests. For instance, the National Institute of Health's National Human Genome Research Institute has indicated that advancements in genomics will lead to a more extensive adoption of personalized medicine, facilitating targeted therapies for various conditions.
This shift towards precision medicine is anticipated to enhance the requirement for comprehensive laboratory testing solutions in clinical laboratories across the US. Consequently, hospitals and healthcare providers are increasingly collaborating with established companies like Quest Diagnostics and LabCorp to leverage these advancements, which drives market maturity and expansion.
The rising focus on preventive healthcare is propelling the US Clinical Reference Laboratories Market Industry. A report by the Healthcare Cost and Utilization Project indicates that preventive services are gaining traction as they support early detection and treatment, reducing healthcare costs in the long run. According to the National Health Interview Survey, 92.3 million adults in the US reported receiving a preventive service in 2020, with blood tests being among the most commonly utilized.
As a result, clinical laboratories are increasingly integrating comprehensive screening panels to accommodate this trend. Major players in the market, such as Mayo Clinic Laboratories, are expanding their service offerings to cater to the growing demand for preventive testing, aligning with the objectives of healthcare policies that aim to enhance patient outcomes through early diagnosis.
The expansion of health insurance coverage is a vital growth driver for the US Clinical Reference Laboratories Market Industry. The Affordable Care Act has significantly increased the number of insured individuals in the US, leading to greater access to a variety of healthcare services, including laboratory testing. According to the U.S. Department of Health and Human Services, the uninsured rate has dropped from 16% in 2010 to approximately 9% in 2020.
This increase in insurance coverage has translated into higher utilization rates of clinical laboratory services, as patients are more likely to seek testing when they have financial protection. Companies such as BioReference Laboratories are responding by developing partnerships with insurers to enhance coverage for laboratory services, which boosts the overall market growth.
The Service Provider segment within the US Clinical Reference Laboratories Market showcases a diverse range of entities that cater to diagnostic testing and laboratory services, playing a crucial role in healthcare delivery. This segment comprises various types of providers including Stand Alone laboratories, Hospital-Based facilities, and Clinical Based services. Stand Alone laboratories often dominate the landscape due to their ability to focus exclusively on diagnostic testing, providing rapid results, which is essential for timely patient care.
The growing emphasis on patient-centered care and personalized medicine strongly influences this segment, creating opportunities for providers to offer specialized tests and services that address individual patient needs. Factors propelling market growth include an increasing prevalence of chronic diseases, advancements in laboratory technologies, and a growing acceptance of laboratory testing as critical components of disease management protocols. Yet, challenges such as regulatory compliance, the need for skilled workforce, and the pressure to maintain cost-effective operations persist. As such, the Service Provider segment stands as a cornerstone of the US Clinical Reference Laboratories Market, driving advancement and innovation in diagnostic services while remaining adaptable to the continually evolving healthcare landscape. Overall, this segment not only underpins laboratory operations but also significantly impacts patient outcomes, establishing itself as an indispensable aspect of contemporary medical practice.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Clinical Reference Laboratories Market is experiencing considerable growth in its Applications segment, which encompasses diverse areas crucial for healthcare advancement. Key components include Clinical Trials, which play a pivotal role in assessing new treatments and therapies, thereby driving innovation and ensuring patient safety. Laboratory Medicine significantly contributes to diagnostic accuracy and disease management by providing essential data for clinical decision-making, with advancements in technology enhancing testing capabilities.
With ongoing investment in Research and Development for new technologies and the rise in chronic diseases, the demand for efficient laboratory services is projected to increase. As healthcare systems in the US continuously evolve, there is an amplified focus on value-based care, thus elevating the importance of accurate diagnostics and laboratory services in improving patient outcomes and reducing healthcare costs. These factors collectively strengthen the US Clinical Reference Laboratories Market, indicating positive trends ahead as stakeholders adapt to changing industry dynamics.
The US Clinical Reference Laboratories Market is characterized by a dynamic landscape, driven by increasing demand for diagnostic testing and advancements in laboratory technology. In this competitive environment, organizations vie for market share through innovation, service offerings, and strategic partnerships. The market has seen significant growth due to heightened awareness of preventive healthcare, the rise of chronic diseases, and a growing aging population necessitating more accurate and timely laboratory services. Companies within this sector are focused on expanding their capabilities by integrating advanced technologies, increasing test volumes, and offering a diverse portfolio of diagnostic services that can cater to a broad array of patient needs.
HealthQuest has established a strong presence in the US Clinical Reference Laboratories Market by delivering an extensive range of reliable diagnostic services. The company is known for its robust network that allows it to maintain high levels of efficiency and swift turnaround times for tests. HealthQuest emphasizes a commitment to quality control and operational excellence, which has positioned it as a trusted partner for healthcare providers. Among its strengths is the ability to leverage collaborative relationships with healthcare institutions, enhancing its visibility and customer loyalty within the competitive landscape. Additionally, HealthQuest invests in continuous training and development of its staff, ensuring that the laboratory operations remain at the forefront of industry standards.
BioReference Laboratories is another key player in the US Clinical Reference Laboratories Market, recognized for its comprehensive suite of laboratory services, which includes genetic testing, routine clinical tests, and specialized assays. The company's extensive infrastructure supports a wide geographical reach, facilitating its strong market presence. Key strengths of BioReference Laboratories include its commitment to innovation, as evidenced by the launch of cutting-edge testing technologies and services to meet evolving healthcare needs. The company has also pursued strategic mergers and acquisitions to bolster its capabilities and expand its service offerings, positioning itself competitively against other players in the market. BioReference Laboratories has further enhanced its standing through partnerships with healthcare systems, allowing it to effectively service a large volume of patients while maintaining a focus on quality, accuracy, and a customer-centric approach in all its operations.
Recent developments in the US Clinical Reference Laboratories Market include significant growth driven by an increase in demand for diagnostic testing, particularly in response to the COVID-19 pandemic. Companies like LabCorp and Quest Diagnostics have reported strong quarterly earnings, attributed to a higher volume of testing. In September 2023, Aegis Sciences Corporation announced the acquisition of a specialized laboratory, enhancing its capabilities in substance abuse testing and solidifying its market presence.
Furthermore, BioReference Laboratories has expanded its offerings by integrating new genomic testing services, responding to the increasing trend towards personalized medicine. Meanwhile, Exact Sciences continues to expand its product portfolio, particularly in colorectal cancer screening, impacting the market valuation positively.
Over the past two years, companies have also focused on technological integration, with Thermo Fisher Scientific emphasizing its advancements in automation and data management solutions. Reports indicate a strong competitive environment, with organizations rapidly adapting to emerging healthcare needs and regulatory changes, ensuring their relevance in a fast-evolving landscape. This market expansion and consolidation reflect the ongoing evolution of clinical reference labs in the United States.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 11.04(USD Billion) |
| MARKET SIZE 2024 | 12.98(USD Billion) |
| MARKET SIZE 2035 | 27.17(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.946% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | HealthQuest, BioReference Laboratories, Mayo Clinic Laboratories, Sonora Quest Laboratories, ARCpoint Labs, Exact Sciences, LabCorp, Thermo Fisher Scientific, Aegis Sciences Corporation, Laboratory Corporation of America, Quest Diagnostics, Fulgent Genetics, Genoptix, PathGroup, Clinical Pathology Laboratories |
| SEGMENTS COVERED | Service Provider, Applications |
| KEY MARKET OPPORTUNITIES | Telehealth integration, Personalized medicine advancements, Increased demand for genetic testing, Rising chronic disease prevalence, Automation in laboratory processes |
| KEY MARKET DYNAMICS | rising demand for diagnostic testing, increasing prevalence of chronic diseases, advancements in laboratory technology, regulatory compliance and quality assurance, shift towards personalized medicine |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Clinical Reference Laboratories Market is expected to be valued at 12.98 billion USD in 2024.
By 2035, the US Clinical Reference Laboratories Market is projected to reach a value of 27.17 billion USD.
The market is expected to grow at a CAGR of 6.946% from 2025 to 2035.
The Hospital-Based Market segment is expected to dominate with an estimated value of 5.0 billion USD in 2024.
The Stand Alone segment is projected to be valued at 9.0 billion USD by 2035.
Key players include HealthQuest, BioReference Laboratories, Mayo Clinic Laboratories, and LabCorp among others.
The Clinical Based segment is expected to grow from 3.48 billion USD in 2024 to 8.17 billion USD by 2035.
Emerging trends include increased demand for diagnostic services and advances in technology driving market growth.
Challenges include regulatory hurdles and competition from emerging diagnostic technologies.
Opportunities include expanding services in personalized medicine and telehealth diagnostics.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
